Inactive Instrument
Synergy Pharmaceuticals Inc Share Price Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2014 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 14/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| +3.98% | +5.55% | +76.40% | +136.18% | 56.21B | |
| -3.12% | +5.11% | +71.57% | +94.67% | 55.38B | |
| +3.01% | +7.54% | -10.59% | -10.23% | 23.75B | |
| +2.18% | +4.58% | +11.21% | +426.51% | 23.19B | |
| +3.64% | +10.54% | +39.81% | -4.50% | 18.14B | |
| +4.11% | +8.89% | +44.60% | -27.73% | 16.84B | |
| +2.57% | +20.26% | +181.98% | +355.99% | 15.86B | |
| +1.78% | +3.13% | +23.92% | +186.96% | 13.56B | |
| +7.20% | +10.70% | +42.91% | - | 12.97B | |
| Average | -2.66% | +7.25% | +53.53% | +144.73% | 26.21B | |
| Weighted average by Cap. | +1.98% | +6.09% | +57.25% | +135.37% |
Employees
-
